Takara Bio Future Growth
Future criteria checks 3/6
Takara Bio is forecast to grow earnings and revenue by 24.8% and 4.1% per annum respectively. EPS is expected to grow by 24.8% per annum. Return on equity is forecast to be 4.6% in 3 years.
Key information
24.8%
Earnings growth rate
24.8%
EPS growth rate
Biotechs earnings growth | 22.2% |
Revenue growth rate | 4.1% |
Future return on equity | 4.6% |
Analyst coverage | Low |
Last updated | 11 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 51,574 | 5,163 | 5,392 | 10,412 | 2 |
3/31/2026 | 50,668 | 4,449 | 52 | 9,571 | 3 |
3/31/2025 | 47,447 | 3,737 | -2,514 | 8,000 | 3 |
3/31/2024 | 44,818 | 2,058 | -6,913 | 7,601 | 3 |
12/31/2023 | 47,670 | 1,571 | 9,885 | 24,118 | N/A |
9/30/2023 | 64,671 | 8,558 | 16,234 | 30,312 | N/A |
6/30/2023 | 73,216 | 12,424 | 27,265 | 33,450 | N/A |
3/31/2023 | 78,142 | 16,012 | 31,150 | 36,897 | N/A |
12/31/2022 | 82,246 | 20,080 | -2,576 | 4,845 | N/A |
9/30/2022 | 68,735 | 18,378 | -4,369 | 5,743 | N/A |
6/30/2022 | 66,529 | 17,731 | -5,985 | 5,147 | N/A |
3/31/2022 | 67,699 | 19,849 | -5,418 | 6,985 | N/A |
12/31/2021 | 62,196 | 18,185 | 10,941 | 21,366 | N/A |
9/30/2021 | 60,244 | 17,282 | 10,000 | 18,304 | N/A |
6/30/2021 | 54,420 | 15,168 | 5,860 | 16,136 | N/A |
3/31/2021 | 46,086 | 9,547 | 5,256 | 13,943 | N/A |
12/31/2020 | 39,556 | 6,837 | 1,663 | 9,629 | N/A |
9/30/2020 | 35,508 | 4,018 | -163 | 7,183 | N/A |
6/30/2020 | 32,853 | 2,632 | 1,688 | 5,876 | N/A |
3/31/2020 | 34,565 | 3,819 | 2,356 | 6,339 | N/A |
12/31/2019 | 34,511 | 4,277 | 578 | 6,324 | N/A |
9/30/2019 | 34,921 | 4,012 | -321 | 6,779 | N/A |
6/30/2019 | 35,644 | 4,216 | 1,108 | 6,703 | N/A |
3/31/2019 | 35,841 | 3,657 | -194 | 5,783 | N/A |
12/31/2018 | 35,554 | 3,355 | 3,663 | 7,495 | N/A |
9/30/2018 | 35,556 | 3,753 | 5,110 | 7,238 | N/A |
6/30/2018 | 34,804 | 3,345 | 5,045 | 6,970 | N/A |
3/31/2018 | 32,312 | 2,335 | 2,436 | 3,935 | N/A |
12/31/2017 | 31,376 | 859 | 1,285 | 2,683 | N/A |
9/30/2017 | 30,302 | 987 | N/A | 2,146 | N/A |
6/30/2017 | 29,424 | 1,089 | N/A | 2,198 | N/A |
3/31/2017 | 29,375 | 1,352 | N/A | 3,584 | N/A |
12/31/2016 | 29,668 | 2,282 | N/A | 3,142 | N/A |
9/30/2016 | 29,671 | 1,856 | N/A | 3,931 | N/A |
6/30/2016 | 30,274 | 1,655 | N/A | 3,525 | N/A |
3/31/2016 | 29,729 | 1,334 | N/A | 3,021 | N/A |
12/31/2015 | 29,382 | 1,660 | N/A | 3,556 | N/A |
9/30/2015 | 28,255 | 704 | N/A | 3,073 | N/A |
6/30/2015 | 26,951 | 909 | N/A | 2,977 | N/A |
3/31/2015 | 25,969 | 963 | N/A | 3,558 | N/A |
12/31/2014 | 25,031 | 844 | N/A | 2,409 | N/A |
9/30/2014 | 24,599 | 1,647 | N/A | 2,424 | N/A |
6/30/2014 | 24,514 | 1,742 | N/A | 3,316 | N/A |
3/31/2014 | 23,905 | 1,470 | N/A | 2,251 | N/A |
12/31/2013 | 22,815 | 1,291 | N/A | 2,171 | N/A |
9/30/2013 | 21,828 | 1,375 | N/A | 2,213 | N/A |
6/30/2013 | 20,630 | 1,103 | N/A | 1,823 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4974's forecast earnings growth (24.8% per year) is above the savings rate (0.2%).
Earnings vs Market: 4974's earnings (24.8% per year) are forecast to grow faster than the JP market (9.4% per year).
High Growth Earnings: 4974's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 4974's revenue (4.1% per year) is forecast to grow slower than the JP market (4.4% per year).
High Growth Revenue: 4974's revenue (4.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4974's Return on Equity is forecast to be low in 3 years time (4.6%).